Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation

References

• Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J Intern Med. 2013;274(5):461–468. doi: 10.1111/joim.12114.
   PubMedGoogle Scholar
• Rienstra M, Lubitz SA, Mahida S, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012;125(23):2933–2943. doi: 10.1161/CIRCULATIONAHA.111.069450.
   PubMed Web of Science ®Google Scholar
• Särnholm J, Skúladóttir H, Rück C, et al. Exposure-Based therapy for symptom preoccupation in atrial fibrillation: an uncontrolled pilot study. Behav Ther. 2017;48(6):808–819. doi: 10.1016/j.beth.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36(4):1303–1309. doi: 10.1016/s0735-1097(00)00886-x.
   PubMed Web of Science ®Google Scholar
• Steinberg BA, Shrader P, Pieper K, et al. Frequency and outcomes of reduced dose Non-Vitamin K antagonist anticoagulants: results from ORBIT-AF II (the outcomes registry for better informed treatment of atrial fibrillation II). J Am Heart Assoc. 2018;7(4):e007633.
   PubMed Web of Science ®Google Scholar
• Heidt ST, Kratz A, Najarian K, et al. Symptoms in atrial fibrillation: a contemporary review and future directions. J Atr Fibrillation. 2016;9(1):1422.
   PubMedGoogle Scholar
• Olbers J, Östergren J, Rosenqvist M, et al. Changes in 24-h ambulatory blood pressure following restoration of sinus rhythm in patients with atrial fibrillation. J Hypertens. 2021;39(2):243–249. doi: 10.1097/HJH.0000000000002623.
   PubMed Web of Science ®Google Scholar
• Stahlberg M, Damgaard M, Norsk P, et al. Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy. Europace. 2009;11(9):1160–1167. doi: 10.1093/europace/eup173.
   PubMed Web of Science ®Google Scholar
• Spertus J, Dorian P, Bubien R, et al. Development and validation of the atrial fibrillation effect on QualiTy-of-Life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(1):15–25. doi: 10.1161/CIRCEP.110.958033.
   PubMed Web of Science ®Google Scholar
• Jenkins LS, Brodsky M, Schron E, et al. Quality of life in atrial fibrillation: the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Am Heart J. 2005;149(1):112–120.
   PubMed Web of Science ®Google Scholar
• Wynn GJ, Todd DM, Webber M, et al. The european heart rhythm association symptom classification for atrial fibrillation: validation and improvement through a simple modification. Europace. 2014;16(7):965–972. doi: 10.1093/europace/eut395.
   PubMed Web of Science ®Google Scholar
• Killip T, Baer RA. Hemodynamic effects after reversion from atrial fibrillation to sinus rhythm by precordial shock. J Clin Invest. 1966;45(5):658–671. doi: 10.1172/JCI105381.
   PubMed Web of Science ®Google Scholar
• Sato T, Mitamura H, Kurita Y, et al. Recovery of electrophysiological parameters after conversion of atrial fibrillation. Int J Cardiol. 2001;79(2-3):183–189. doi: 10.1016/s0167-5273(01)00419-3.
   PubMed Web of Science ®Google Scholar
• Graettinger JS, Carleton RA, Muenster JJ. Circulatory consequences of changes in cardiac rhythm produced in atients by transthoracic direct-current shock. J Clin Invest. 1964;43(12):2290–2302. doi: 10.1172/JCI105103.
   PubMed Web of Science ®Google Scholar
• Giglioli C, Nesti M, Cecchi E, et al. Hemodynamic effects in patients with atrial fibrillation submitted to electrical cardioversion. Int J Cardiol. 2013;168(4):4447–4450. doi: 10.1016/j.ijcard.2013.06.150.
   PubMed Web of Science ®Google Scholar
• Allsager CM, Swanevelder J. Measuring cardiac output. BJA CEPD Rev. 2003;3(1):15–19. doi: 10.1093/bjacepd/mkg004.
   Google Scholar
• Okwose NC, Zhang J, Chowdhury S, et al. Reproducibility of inert gas rebreathing method to estimate cardiac output at rest and during cardiopulmonary exercise stress testing. Int J Sports Med. 2019;40(2):125–132. doi: 10.1055/a-0809-5408.
   PubMed Web of Science ®Google Scholar
• Upshaw CB. Jr. Hemodynamic changes after cardioversion of chronic atrial fibrillation. Arch Intern Med. 1997;157(10):1070–1076. doi: 10.1001/archinte.1997.00440310032003.
   PubMedGoogle Scholar
• Khan IA. Atrial stunning: basics and clinical considerations. Int J Cardiol. 2003;92(2–3):113–128. doi: 10.1016/s0167-5273(03)00107-4.
   PubMed Web of Science ®Google Scholar
• Ausubel K, Steingart RM, Shimshi M, et al. Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility. Circulation. 1985;72(5):1037–1043. doi: 10.1161/01.cir.72.5.1037.
   PubMed Web of Science ®Google Scholar
• Kazik A, Wilczek K, Polonski L. Management of diastolic heart failure. Cardiol J. 2010;17(6):558–565.
   PubMed Web of Science ®Google Scholar
• Gronefeld GC, Lilienthal J, Kuck KH, et al. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. Eur Heart J. 2003;24(15):1430–1436. doi: 10.1016/s0195-668x(03)00261-6.
   PubMed Web of Science ®Google Scholar
• Sandhu RK, Smigorowsky M, Lockwood E, et al. Impact of electrical cardioversion on quality of life for the treatment of atrial fibrillation. Can J Cardiol. 2017;33(4):450–455. doi: 10.1016/j.cjca.2016.11.013.
   PubMed Web of Science ®Google Scholar
• Dorian P, Burk C, Mullin CM, et al. Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful? Am Heart J. 2013;166(2):381–387.e8. doi: 10.1016/j.ahj.2013.04.015.
   PubMed Web of Science ®Google Scholar
• Randolph TC, Simon DN, Thomas L, et al. Patient factors associated with quality of life in atrial fibrillation. Am Heart J. 2016;182:135–143. doi: 10.1016/j.ahj.2016.08.003.
   PubMed Web of Science ®Google Scholar
• Zeitler EP, Li Y, Silverstein AP, et al. Effects of ablation versus drug therapy on quality of life by sex in atrial fibrillation: results from the CABANA trial. J Am Heart Assoc. 2023:e027871.
   PubMed Web of Science ®Google Scholar
• Frykman V, Ayers GM, Darpö B, et al. What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter. Am Heart J. 2003;145(4):670–675. doi: 10.1067/mhj.2003.93.
   PubMed Web of Science ®Google Scholar
• Clark DM, Plumb VJ, Epstein AE, et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30(4):1039–1045. doi: 10.1016/s0735-1097(97)00254-4.
   PubMed Web of Science ®Google Scholar
• Olbers J, Jacobson E, Viberg F, et al. Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion. J Clin Hypertens (Greenwich). 2019;21(3):363–368. doi: 10.1111/jch.13496.
   PubMed Web of Science ®Google Scholar
• Hassan M, Wagdy K, Kharabish A, et al. Validation of noninvasive measurement of cardiac output using inert gas rebreathing in a cohort of patients with heart failure and reduced ejection fraction. Circ Heart Fail. 2017;10(3):e003592.
   PubMed Web of Science ®Google Scholar
• Gabrielsen A, Videbaek R, Schou M, et al. Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sci (Lond). 2002;102(2):247–252. doi: 10.1042/CS20010158.
   PubMed Web of Science ®Google Scholar